Interleukin-1 receptor antagonist-based immunotherapy on autoimmune diabetes
碩士 === 國防醫學院 === 微生物及免疫學研究所 === 88 === Insulin-dependent diabetes mellitus (IDDM) is caused by a progressive autoimmune destruction of the insulin-producing b cells in the pancreatic islets of Langerhans. Both genetic predisposition and environmental factors contribute to its pathogenesis. A widely...
Main Author: | 廖健翔 |
---|---|
Other Authors: | Huey-Kang Sytwu |
Format: | Others |
Language: | zh-TW |
Published: |
2000
|
Online Access: | http://ndltd.ncl.edu.tw/handle/03410938336018266922 |
Similar Items
-
Interleukin expression after injury and the effects of interleukin-1 receptor antagonist.
by: Connie S Chamberlain, et al.
Published: (2013-01-01) -
The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse
by: P. Bjrök, et al.
Published: (1992-01-01) -
Interleukin 1-β, Interleukin-1 Receptor Antagonist, and Interleukin 18 in Children with Acute Spontaneous Urticaria
by: E. Machura, et al.
Published: (2013-01-01) -
INCREASING LEVELS OF INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR ANTAGONIST IN BALINESE IDIOPATHIC GRANDMAL EPILEPSY
by: Gelgel Anna-Marita, et al.
Published: (2015-07-01) -
Interleukin-1B and Interleukin-1 Receptor Antagonist in Patients with Helicobacter pylori Associated Diseases
by: Elizaveta S. Ageeva, PhD, et al.
Published: (2012-06-01)